These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4637947)

  • 1. Studies on the quantitative antagonism of analgesics by naloxone and diprenorphine.
    Takemori AE; Hayashi G; Smits SE
    Eur J Pharmacol; 1972 Oct; 20(1):85-92. PubMed ID: 4637947
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of morphine by long acting narcotic antagonists.
    Dykstra LA; McMillan DE; Harris LS
    Psychopharmacologia; 1974; 39(2):151-62. PubMed ID: 4476081
    [No Abstract]   [Full Text] [Related]  

  • 3. The increased efficacy of narcotic antagonists induced by various narcotic analgesics.
    Tulunay FC; Takemori AE
    J Pharmacol Exp Ther; 1974 Sep; 190(3):395-400. PubMed ID: 4416308
    [No Abstract]   [Full Text] [Related]  

  • 4. Electroencephalographic study of pentazocine and buprenorphine.
    Kubicki S; Azcona A
    Acta Anaesthesiol Belg; 1979; 30 Suppl():123-33. PubMed ID: 547656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic parameters of a new narcotic agonist, azidomorphine.
    Knoll J; Fürst S; Vizi ES
    Pharmacology; 1973; 10(6):354-62. PubMed ID: 4784366
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteration of analgesic receptor-antagonist interaction induced by morphine.
    Takemori AE; Oka T; Nishiyama N
    J Pharmacol Exp Ther; 1973 Aug; 186(2):261-5. PubMed ID: 4719780
    [No Abstract]   [Full Text] [Related]  

  • 7. Analgesic and dependence studies with oripavine partial agonists.
    Cowan A; Lewis JW; Macfarlane IR; Whittle BA
    Br J Pharmacol; 1971 Oct; 43(2):461P-462P. PubMed ID: 5168272
    [No Abstract]   [Full Text] [Related]  

  • 8. [Precipitation and prevention of abstinence in acutely morphinized rats and mice: comparisons between naloxone, naltrexone, and diprenorphine (author's transl)].
    Tremblay E; Colombel MC; Jacob J
    Psychopharmacology (Berl); 1976 Aug; 49(1):41-8. PubMed ID: 822446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: The effects of buprenorphine, morphine and pentazocine on turning behaviour and stereotypy induced by apomorphine in the rat.
    Cowan A; Dettmar PW; Walter DS
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():15P. PubMed ID: 2687
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Nov; 207(2):494-503. PubMed ID: 30841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone resistant changes in body temperature of the cat induced by intracerebroventricular injection of pentazocine.
    Clark WG
    Gen Pharmacol; 1979; 10(3):249-55. PubMed ID: 467963
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism by naloxone of tolerance and dependence in mice given a single dose of morphine.
    Yano I; Nishino H; Murano T
    Jpn J Pharmacol; 1979 Jun; 29(3):357-66. PubMed ID: 575393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulus properties of the narcotic antagonist pentazocine: similarity to morphine and antagonism by naloxone.
    Kuhn DM; Greenberg I; Appel JB
    J Pharmacol Exp Ther; 1976 Jan; 196(1):121-7. PubMed ID: 1246006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone, naltrexone, and related noroxymorphones.
    Blumberg H; Dayton HB
    Adv Biochem Psychopharmacol; 1973; 8(0):33-43. PubMed ID: 4794989
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of morphine, nalbuphine and pentazocine on gastric emptying of indigestible solids.
    Asai T
    Arzneimittelforschung; 1998 Aug; 48(8):802-5. PubMed ID: 9748706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narcotic antagonist activity of substituted 1,2,4,5-tetrahydro-3H,3-benzazepines.
    Giering JE; Davidson TA; Shetty BV; Truant AP
    Adv Biochem Psychopharmacol; 1973; 8(0):167-86. PubMed ID: 4800174
    [No Abstract]   [Full Text] [Related]  

  • 17. Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys.
    Goldberg SR; Hoffmeister F; Schlichting U; Wuttke W
    J Pharmacol Exp Ther; 1971 Nov; 179(2):268-76. PubMed ID: 5002481
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
    Cowan A
    Adv Biochem Psychopharmacol; 1973; 8(0):427-38. PubMed ID: 4211992
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
    Picker MJ; Craft RM; Negus SS; Powell KR; Mattox SR; Jones SR; Hargrove BK; Dykstra LA
    J Pharmacol Exp Ther; 1992 Nov; 263(2):668-81. PubMed ID: 1331411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new mixed agonist-antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats.
    Steinfels GF; Young GA; Khazan N
    NIDA Res Monogr; 1981 Feb; 34():138-44. PubMed ID: 6783923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.